PMDD affects a small but meaningful share of people who menstruate. A 2024 review in the U.S. National Library of Medicine's PubMed found that about 3 in 100 met the full diagnosis rules, while about 8 in 100 received a provisional diagnosis before all checks were complete. These figures differ because studies measure symptoms in different ways. PMDD is much less common than PMS.
What percentage of people have PMDD?
Premenstrual dysphoric disorder (PMDD) is estimated to affect a minority of people during their reproductive years. A systematic review and meta-analysis published in 2024 combined 44 studies involving 50,659 participants. It estimated that 3.2% of participants met confirmed diagnostic criteria, compared with 7.7% who met criteria for a provisional diagnosis. In community-based studies that used confirmed diagnoses, the estimate was lower, at 1.6%.
The U.S. Department of Health and Human Services' Office on Women's Health gives a commonly used public-health estimate of up to 5% of women of childbearing age. This is broadly consistent with the finding that PMDD affects a relatively small proportion of the population, although the exact percentage depends on how it is assessed.
Why do estimates of PMDD prevalence vary?
Researchers do not always measure PMDD in the same way. Some studies rely on questionnaires or reports of symptoms, while others use a more detailed assessment to establish whether symptoms follow the required pattern across menstrual cycles. A person who appears to meet the criteria in an initial assessment may not meet every requirement when symptoms are recorded over time.
The 2024 review available through the National Library of Medicine's PubMed found substantial variation between studies. Estimates differed according to the types of participants studied, the continent where a study took place, the diagnostic methods used, and the risk of bias in the research. For this reason, a result from university students or a selected clinical group may not represent the wider population.
Confirmed diagnosis also matters. PMDD is not defined simply by experiencing emotional or physical changes before a period. Symptoms must follow a particular pattern, cause meaningful disruption to daily life, and meet the relevant diagnostic criteria. Prospective symptom tracking over at least two menstrual cycles helps establish whether this pattern is present.
How common is PMDD compared with PMS?
Premenstrual syndrome (PMS) is much more common than PMDD. MedlinePlus, a health information service of the U.S. National Library of Medicine, explains that PMS can involve a range of emotional and physical symptoms before menstruation, while PMDD is less common and causes symptoms that are serious enough to interfere with everyday life.
For example, some people experience temporary irritability, tiredness, bloating, or breast tenderness before their periods. PMDD may involve more disruptive emotional symptoms, such as marked anxiety, depressed mood, anger, or changes in mood and sleep. Symptoms generally follow a recurring relationship with the menstrual cycle. The difference is not simply how many people report premenstrual symptoms, but how the symptoms fit the diagnostic criteria and affect daily functioning.
Because PMS includes a wider range of experiences, statistics about premenstrual symptoms should not be treated as estimates of PMDD. The two conditions overlap in some ways, but their prevalence figures are not interchangeable.
Does PMDD affect people of all ages and backgrounds equally?
PMDD is discussed primarily in relation to people of reproductive age who menstruate. Adolescents can also experience premenstrual disorders, and the American College of Obstetricians and Gynecologists (ACOG) includes both adolescents and reproductive-aged adults in its clinical guidance on these conditions.
However, there is not one reliable prevalence figure that applies equally to every age group, country, or community. Differences in the populations studied and the methods used to assess symptoms make direct comparisons difficult. The available estimates are therefore best understood as research-based ranges rather than exact rates for every population.
When should someone seek an assessment for possible PMDD?
Prevalence statistics cannot determine whether an individual has PMDD. A healthcare professional considers the timing of symptoms, their effect on work, school, relationships, and other daily activities, and whether the same pattern returns across menstrual cycles. Medical history and other relevant information also help the clinician consider whether another condition could explain the symptoms or contribute to them.
MedlinePlus' medical information on PMDD notes that keeping a symptom diary can help a healthcare professional understand when symptoms occur and how long they last. Recording symptoms each day alongside menstrual dates over two cycles can provide useful information for an appointment. An assessment is worth considering when recurring premenstrual symptoms are persistent, worsening, difficult to interpret, or disruptive to everyday life.
The main takeaway is that PMDD is less common than PMS, with research suggesting that confirmed cases affect a small proportion of people who menstruate. Differences in research methods explain why published estimates do not always match. Regardless of how common the condition is, recurring symptoms that substantially affect daily life deserve appropriate clinical attention.